Raqia Therapeutics begins operations in the Harvard Pagliuca Life Labs. Raqia is a new company based on technology developed in the Novina lab. Clinical advisors include Ken Anderson and Nikhil Munshi, who will help translate the BAT-CAR technology for patients with multiple myeloma.
Raqia Therapeutics launched!
Collaboration with Takeda
The Novina Lab began work on two sponsored research agreement with Takeda regarding the platform for detecting RNA-protein interactions.
Novina Lab News